NIOX Group Plc logo

NIOX Group Plc(LSE) NIOX

Market Cap£290.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-76%
5 Year+56%
1 Year-4%
1 Month+2%
£0.69
-0.29%
-0.00Today
NIOX Group Plc last closing stock price
MetricPriceDate
Last closeGBX 68.802026-10-20
NIOX Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.47%GBX 67.802026-10-13
1 month+2.38%GBX 67.202026-09-18
3 month+11.33%GBX 61.802026-07-22
Year to date+3.61%GBX 66.402025-12-31
1 year-4.44%GBX 72.002025-10-20
3 year+3.15%GBX 66.702023-10-20
5 year+55.76%GBX 44.172021-10-21
Since inception-75.53%GBX 2.822014-03-13

NIOX Group Plc Financials at a Glance

Market Cap

£290.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£93.50M

Net Income (TTM)

£12.20M

EPS (TTM)

£0.02

P/E Ratio

41.32

Dividend

£0.02

Beta (Volatility)

0.01 (Low)

Price

£0.69

Volume

12,865

Open

£0.66

Previous Close

£0.69

Daily Range

£0.66 - £0.69

52-Week Range

£0.54 - £0.74

Estimated Earnings Date

Mar 23, 2027

NIOX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NIOX Group Plc

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.

Industry

Healthcare Equipment and Supplies

Employees

97

CEO

Jonathan Emms

Headquarters

Oxford, OX OX4 4GA, GB

NIOX Financials

Key Financial Metrics (TTM)

Gross Margin

60.42%

Operating Margin

21.89%

Net Income Margin

14.74%

Return on Equity

10.01%

Return on Capital

14.32%

Return on Assets

9.58%

Earnings Yield

2.42%

Dividend Yield

2.25%

Payout Ratio

92.86%

Stock Overview

Market Cap

£290.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

420.87M

Volume

12.87K

Avg. Volume

575.47K

Financials (TTM)

Gross Profit

£57.20M

Operating Income

£19.70M

EBITDA

£28.40M

Operating Cash Flow

£31.40M

Capital Expenditure

-£100.00K

Free Cash Flow

£31.30M

Cash & ST Invst.

£16.80M

Total Debt

£700.00K

NIOX Group Plc Performance Analysis

NIOX Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 31,300,00012.2%
20232023-12-31GBP 36,800,00017.6%
20242024-12-31GBP 41,800,00013.6%
20252025-12-31GBP 48,700,00016.5%
NIOX Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-1.0%
Q22025-06-3021.2%
Q42025-12-31-6.7%
Q22026-06-302.1%
NIOX Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.04337.3%
20232023-12-31GBP 0.02-34.4%
20242024-12-31GBP 0.01-65.1%
20252025-12-31GBP 0.0297.6%
NIOX Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-118.6%
Q22025-06-30872.2%
Q42025-12-31-81.3%
Q22026-06-30430.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£24.00M

+14.3%

Gross Profit

£14.70M

-3.3%

Gross Margin

61.25%

N/A

Market Cap

£290.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£2.99M

N/A

Employees

97

N/A

Net Income

£5.90M

+34.1%

EBITDA

£7.80M

+18.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£16.80M

-21.9%

Total Debt

£700.00K

-22.2%

Accounts Receivable

£6.80M

+47.8%

Inventory

£7.70M

+87.8%

Long Term Debt

£200.00K

-33.3%

Short Term Debt

£500.00K

-16.7%

Return on Assets

9.58%

N/A

Return on Invested Capital

15.69%

N/A

Free Cash Flow

£3.90M

-32.8%

Operating Cash Flow

£3.90M

-33.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EKF.LEKF Diagnostics Holdings plc
£0.25+0.00%
IHC.LInspiration Healthcare Group plc
£0.18-2.70%
SUN.LSurgical Innovations Group plc
£0.00+0.00%
AMS.LAdvanced Medical Solutions Group plc
£2.83+0.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$98.65+5.32%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.63-5.28%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.52-3.55%
TQQQProShares Trust - ProShares UltraPro Qqq
$70.64+3.56%

Questions About NIOX

What is the current price of NIOX Group Plc?

NIOX Group Plc is trading at £0.69 per share.

What is the 52-week range for NIOX Group Plc?

Over the past 52 weeks, NIOX Group Plc has traded between £0.54 and £0.74.

How much debt does NIOX Group Plc have?

As of the most recent reporting period, NIOX Group Plc reported total debt of £1.00M.

How much cash does NIOX Group Plc have on hand?

NIOX Group Plc reported £19.90M in cash and cash equivalents in its most recent financial results.

What is NIOX Group Plc’s dividend yield?

NIOX Group Plc currently has a dividend yield of 2.25%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.